Markets
In this photo illustration, a HIMS logo seen displayed on a...
(Avishek Das/Getty Images)

Hims rises on revenue beat, discloses it’s again in partnership talks with Novo

Hims also disclosed on Monday that it’s in talks with Novo Nordisk to make the drugmaker’s weight-loss drugs available on its platform. Last time, that didn’t go so well.

J. Edward Moreno

Hims & Hers reported third-quarter earnings results that missed Wall Street estimates but revenue that blew expectations out of the water. The company also said its talking with Novo Nordisk again about a potential deal to distribute its branded weight-loss drugs.

The company reported diluted earnings per share of $0.06, less than the $0.09 analysts polled by FactSet were expecting. Hims also reported $598.9 million in sales, significantly more than the $580.2 million the Street was penciling in.

The company narrowed its full-year revenue guidance to about $2.35 billion from between $2.3 billion and $2.4 billion.

Hims also disclosed on Monday that it’s in talks with Novo to make its branded weight-loss drugs available on the telehealth company’s platform. The two previously had a partnership that ended abruptly in June after Novo accused Hims of “illegal mass compounding and deceptive marketing.”

Hims has been looking for ways to spark sales growth as its core sexual health business slows down and its ability to sell weight-loss treatments remains on shaky ground. In recent months, the company has introduced testosterone treatments and menopause regimens, as well as GLP-1 micro-dosing options.

Additionally, the company disclosed that its continuing to explore international expansion in key markets including Brazil, the U.K., Germany, and Australia. Earlier this year, the company acquired a European peer, Zava, for $265.7 million, and announced plans to expand to Canada in 2026 to offer generic versions of Novos weight-loss shot.

Hims said it plans to launch comprehensive lab testing capabilities in the near future. That will support its upcoming longevity specialty as well as its injectable testosterone offerings, both of which it says are coming next year.

More Markets

See all Markets
markets

OpenAI’s massive custom chip deal with Broadcom is reportedly facing financing difficulties

OpenAI’s plan to purchase 10 gigawatts worth of custom AI chips from Broadcom, a deal announced in October, is running into some financial difficulties, per The Information.

A report, citing an internal memo and people involved in the talks, says that that the custom chip designer is being asked to finance the initial $18 billion in chip production, and is only willing to do so if Microsoft buys 40% of these processors or OpenAI finds other buyers.

Shares of Broadcom sank to session lows following this news, but pared most of that retreat thereafter.

Microsoft recently revised its agreement with the ChatGPT maker to end revenue-sharing payments from the former to the latter. That’s seemingly a signal of the tech behemoth’s reluctance to contribute as much to OpenAI’s massive cash burn going forward.

All in all, it appears as though Broadcom is willing to meet OpenAI more than halfway in a bid to make sure the parties can secure capacity for these chips to be produced. The report concludes:

Broadcom had long insisted that OpenAI put up one dollar of its own for every dollar Broadcom provided in financing, a typical arrangement to limit the chip vendor’s risks. That requirement had become a sticking point in the talks, according to the memo and an executive involved in the talks.

But Broadcom recently decided to relax that demand and invest more capital up-front than OpenAI, breaking from Broadcom’’s “long-held hard-line requirement,” the OpenAI memo said.

markets

Whirlpool tumbles on Q1 earnings, says war is causing “recession-level” decline in US appliance demand

Shares of home-appliance giant Whirlpool Corp. are tumbling on Thursday following its Q1 earnings and stark warning about consumer confidence.

According to Whirlpool, the war with Iran “resulted in recession-level industry decline in the US as consumer confidence collapsed in late February and March.”

The company’s Q1 sales were down about 10% year over year. In April, Whirlpool issued its “largest price increase in more than a decade,” with costs for consumers rising 10%. US appliance demand dropped 7.4% in Q1, Whirlpool said, including a 10% drop in March.

“This level of industry decline is similar to what we have observed during the global financial crisis and even higher than during other recessionary periods,” CEO Marc Bitzer said on the company’s earnings call.

Whirlpool shares were down more than 20% in premarket trading, but pared some of those losses in early trading. It remains on pace for one of its worst trading days in company history.

markets

Krispy Kreme jumps on narrower Q1 loss and “significant progress on turnaround”

Krispy Kreme’s shares are climbing this morning, with the stock ticking up around 5% as the market opened after the company reported narrowing losses and highlighted the success of its turnaround efforts before the bell.

For the quarter ended March 29, 2026, Krispy Kreme trimmed its net loss to $22.8 million, down from $33.3 million a year earlier, though still wider than the $10.8 million loss analysts had penciled in (compiled by Bloomberg). Adjusted EBITDA for Q1 came in at $33.1 million, a little more than the $30.6 million that analysts had been expecting.

CEO Josh Charlesworth struck an optimistic note around the earnings, commenting that Q1 “highlighted significant progress across every pillar of our turnaround plan” and that management expects “this momentum to continue through 2026, driven by profitable growth in the U.S. with key strategic partners, higher digital sales, and international expansion.”

The donut chain is tightening its belt quicker than previously anticipated and expects a net leverage ratio of less than 5.5x in 2026, where they’d expected the level to remain at or below 5.5x last quarter. DNUT also expects more than $15 million in cash flow by the end of the fiscal year as it tightens its debt reduction target.

The company’s newly introduced FY2026 net revenue outlook, forecast to be between $1.25 billion and $1.35 billion, fell below Wall Street’s $1.46 billion estimates — a discrepancy that Krispy Kreme addressed by saying that analyst expectations don’t yet reflect recent asset sales.

markets

Datadog surges after boosting 2026 sales forecast, pulling software stocks higher

Shares of Datadog are surging after the cloud-monitoring platform announced Q1 results that beat Wall Street forecasts on the top and bottom lines while hiking its full year sales guidance.

Key numbers:

  • Revenue of $1.01 billion (up 32% year over year and above analyst estimates of $957.8 million).

  • Adjusted EPS of $0.60 (estimate: $0.52).

Full-year revenue guidance was lifted to $4.3 billion to $4.34 billion from the earlier range of $4.06 billion to $4.1 billion. Management also raised the company’s full-year guidance, now giving an adjusted EPS outlook of $2.36 to $2.44.

The boost to the sales outlook isn’t just helping Datadog, but also the beaten-down semiconductor industry at large. The iShares Expanded Tech Software ETF is up about 4% as of 10:46 a.m. ET, with the likes of Palo Alto Networks, GitLab, Palantir, Atlassian, and CrowdStrike outperforming.

“Overall, we view this as a transformational print/guide for DDOG as the company continues to demonstrate that AI is a powerful demand catalyst rather than a disruptive threat with mission-critical positioning across cloud migration, digital transformation, and now AI training/inference workloads creating a multi-year runway for accelerating growth and continued share gains,” wrote Wedbush analyst Dan Ives in the wake of this report, boosting his price target to $220 from $190.

The rally comes as Datadog announced that it has received FedRAMP High certification, meeting federal government cloud security and compliance standards for handling sensitive unclassified information. The certification is designed to protect controlled unclassified information in cloud environments through strict security controls.

“This milestone reinforces Datadog’s leadership in cloud security and compliance, and sets a new standard for observability platforms in regulated sectors,” said Emilio Escobar, CISO at Datadog.

Going into the report, Datadog had gained over 47% year to date.

markets

Vistra rises after reporting better-than-expected Q1 numbers

Power provider Vistra, a key AI energy trade, reported better-than-expected results early Thursday, sending shares up in premarket trading.

The Texas-based company, which supplies nuclear energy, natural gas, and coal-fueled power to wholesale and retail markets, reported:

  • Net income of $1.029 billion (including a massive $723 million unrealized gain from hedges expected to settle in future years) vs. Wall Street expectations for $434.2 million.

  • Adjusted EBITDA of $1.49 billion vs. expectations for $1.44 billion, per FactSet.

  • Revenue of $5.6 billion vs. an estimated $5.1 billion, per Bloomberg.

Vistra reaffirmed its 2026 Ongoing Operations Adjusted EBITDA guidance range of $6.8 billion to $7.6 billion and Ongoing Operations Adjusted Free Cash Flow before Growth range of $3.925 billion to $4.725 billion.

The companys shares soared 258% in 2024 amid a flurry of excitement over the AI energy boom. Last year was more muted, with the stock rising 17%. So far in 2026, shares were down roughly 4% through yesterday’s close.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Derivatives, LLC, or Robinhood Money, LLC. Futures and event contracts are offered through Robinhood Derivatives, LLC.